Nasdaq: GENB
Generate Biomedicines insiders
The officers, directors and 10% owners of Generate Biomedicines, Inc. who hold the most stock, valued at the live GENB price.
$10.37
GENB today −$10K (−0.10%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 7
- Their GENB stock
- $322M
- Market value
- $1.34B
- Held by ranked insiders
- 24.0%
Insiders by value of GENB holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Nutritional Health LTP Fund General Partner LLC | 10% owner | 9,120,069 | $94.6M | 7.06% | Corporate |
| 2 | Flagship Pioneering Fund VI, L.P. | 10% owner | 9,120,069 | $94.6M | 7.06% | Corporate |
| 3 | Nutritional Health LTP Fund, L.P. | 10% owner | 8,338,819 | $86.5M | 6.46% | Corporate |
| 4 | Michael Nally | Chief Executive Officer | 2,889,154 | $30.0M | 2.24% | 3785th |
| 5 | Gevorg Grigoryan | Chief Technology Officer | 659,973 | $6.8M | 0.51% | 11590th |
| 6 | Stephane Bancel | Director | 460,829 | $4.8M | 0.36% | 211th |
| 7 | Frances Arnold | Director | 452,535 | $4.7M | 0.35% | 6760th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Generate Biomedicines; see each profile for the filing.